↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

16 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 150 mg double-blinded secukinumab Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
2 150 mg open-label secukinumab Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
3 300 mg double-blinded secukinumab Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
4 Secukinumab Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 7件: 13, 37, 41, 46, 160, 269, 271 💬
5 Secukinumab (150 mg) Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
6 Secukinumab (75 mg) Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
7 Secukinumab (ain457) Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 46 💬
8 Secukinumab (ain457) 150 mg s.c. Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
9 Secukinumab 150 mg (2 injections per dose Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 269 💬
10 Secukinumab 150 mg provided in 1.0 ml pre-filled syringes (pfss) for sc injection. Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
11 Secukinumab 150 mg/1 ml solution for injection Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 2件: 37, 271 💬
12 Secukinumab 150 milligram [cosentyx] Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
13 Secukinumab 150mg Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 37 💬
14 Secukinumab 300 mg, s.c. Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 41 💬
15 Secukinumab 300mg Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 37 💬
16 Secukinumab 75 mg/0.5 ml solution for injection Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬